1978 1980 1981 1982 1983 1984

1985 1986 1987 1988 1989 1990

1992 1993 1994 1995 1996 1997

1998 1999 2000 2001 2002 2003

2004 2005 2006 2007 2008

Absence of p16/MTS1 gene mutations in human prostate cancer.
Chen W, Weghorst CM, Sabourin CL, Wang Y, Wang D, Bostwick DG, Stoner GD.

Florid cystitis glandularis of intestinal type with mucin extravasation: a mimic of adenocarcinoma.
Young RH, Bostwick DG.

Comparing the age at prostate cancer diagnosis in humans and dogs.
Waters DJ, Patronek GJ, Bostwick DG, Glickman LT.

Platelet-derived growth factor A and B chains and the alpha and beta receptors in prostatic intraepithelial neoplasia.
Fudge K, Bostwick DG, Stearns ME.

Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens.
Pisansky TM, Blute ML, Suman VJ, Bostwick DG, Earle JD, Zincke H.

cis-trans lycopene isomers, carotenoids, and retinol in the human prostate.
Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ, Erdman JW Jr.

Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines.
Kuntzman RS, Malek RS, Barrett DM, Bostwick DG.

Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens.
Qian J, Bostwick DG, Takahashi S, Borell TJ, Brown JA, Lieber MM, Jenkins RB.

Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.
Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG, Thibodeau SN.

Transurethral enzymatic ablation of the prostate: canine model.
Harmon WJ, Barrett DM, Qian J, Lauvetz RW, Bostwick DG, Gocken M.

Molecular biology of prostatic intraepithelial neoplasia.
Bostwick DG, Pacelli A, Lopez-Beltran A.

Origins of prostate cancer.
Montironi R, Bostwick DG, Bonkhoff H, Cockett AT, Helpap B, Troncoso P, Waters D.

Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.
Bostwick DG.

Pigment in prostatic epithelium and adenocarcinoma: a potential source of diagnostic confusion with seminal vesicular epithelium.
Amin MB, Bostwick DG.

Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma.
Allam CK, Bostwick DG, Hayes JA, Upton MP, Wade GG, Domanowski GF, Klein MA, Boling EA, Stilmant MM.

Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies.
Bostwick DG, Wheeler TM, Blute M, Barrett DM, MacLennan GT, Sebo TJ, Scardino PT, Humphrey PA, Hudson MA, Fradet Y, Miller GJ, Crawford ED, Blumenstein BA, Mahran HE, Miles BJ.

Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.
Brown JA, Takahashi S, Alcaraz A, Borell TJ, Anderl KL, Qian J, Persons DL, Bostwick DG, Lieber MM, Jenkins RB.

Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy.
Lerner SE, Blute ML, Bergstralh EJ, Bostwick DG, Eickholt JT, Zincke H.

Immunolocalization of glycoprotein A-80 in prostatic carcinoma and prostatic intraepithelial neoplasia.
Gould VE, Doljanskaia V, Gooch G, Bostwick DG.

Microvascular invasion of the seminal vesicles in adenocarcinoma of the prostate.
Graham SD Jr, Napalkov P, Watts L, Salomao D, Bostwick DG.

Prospective analysis of the incidence of ipsilateral adrenal metastasis in localized renal cell carcinoma.
Kletscher BA, Qian J, Bostwick DG, Blute ML, Zincke H.

Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmert-Buck MR, Linehan WM.

Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration.
Alexander EE, Qian J, Wollan PC, Myers RP, Bostwick DG.

Temperature-correlated histopathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia.
Larson TR, Bostwick DG, Corica A.

Prediction of capsular perforation and seminal vesicle invasion in prostate cancer.
Bostwick DG, Qian J, Bergstralh E, Dundore P, Dugan J, Myers RP, Oesterling JE.

The definition and preoperative prediction of clinically insignificant prostate cancer.
Dugan JA, Bostwick DG, Myers RP, Qian J, Bergstralh EJ, Oesterling JE.

Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials.
Bostwick DG, Aquilina JW.

Potential markers of aggressiveness in prostatic intraepithelial neoplasia detected by fluorescence in situ hybridization.
Qian J, Jenkins RB, Bostwick DG.

Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma.
Bostwick DG.